The Discovery of the MCH-1 Receptor Antagonist NGD-4715 for the Potential Treatment of Obesity

2017 
The authors of this article were previously employed by Neurogen Corporation, a subsidiary of Ligand Pharmaceuticals.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    34
    References
    1
    Citations
    NaN
    KQI
    []